Cubist Systematic Strategies’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,251
| Closed | -$563 | – | 2846 |
|
|
2024
Q1 | $563 | Buy |
+1,251
| New | +$563 | ﹤0.01% | 2128 |
|
|
2022
Q3 | – | Sell |
-92
| Closed | -$2K | – | 4009 |
|
|
2022
Q2 | $2K | Sell |
92
-34
| -27% | -$739 | ﹤0.01% | 3782 |
|
|
2022
Q1 | $5K | Sell |
126
-190
| -60% | -$7.54K | ﹤0.01% | 3484 |
|
|
2021
Q4 | $18K | Buy |
316
+90
| +40% | +$5.13K | ﹤0.01% | 3383 |
|
|
2021
Q3 | $16K | Sell |
226
-116
| -34% | -$8.21K | ﹤0.01% | 2897 |
|
|
2021
Q2 | $33K | Buy |
+342
| New | +$33K | ﹤0.01% | 2823 |
|